University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 22 of 25

COMPLETED Phase 2

Restoring Skill in Walking

NCT00177359
COMPLETED Phase 1

Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01515137
COMPLETED Phase 2

Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer

NCT00222729
TERMINATED Phase 4

Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)

NCT01233635
COMPLETED Phase 2

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

NCT00226239
COMPLETED

Pediatric Facial Fracture Study

NCT00759486
COMPLETED Phase 2

Acupuncture for Urinary Incontinence

NCT00297427
COMPLETED

Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients

NCT00235664
COMPLETED Phase 3

Voice Therapy for Teachers With Voice Problems

NCT00222937
TERMINATED Phase 3

Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients

NCT00235651
COMPLETED

Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit

NCT00177814
COMPLETED Phase 1

The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants

NCT00167388
COMPLETED Phase 4

Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens

NCT00177333
COMPLETED Phase 1

Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients

NCT00177840
COMPLETED

Pharmacodynamic Parameters of Two Different Doses of Cefepime

NCT00177736
COMPLETED

Voriconazole as Prophylaxis for Liver Transplant Recipients

NCT00177788
COMPLETED Phase 2

Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

NCT00167310
COMPLETED Phase 2

Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study

NCT00129441
COMPLETED Phase 4

Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports

NCT00222911
COMPLETED

Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression

NCT00178087
COMPLETED

Towards Reducing Resistance and Hematological Toxicity of Linezolid

NCT00177723
COMPLETED Phase 1

A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis

NCT00156403
COMPLETED

Invasive Fungal Infections Surveillance Initiative

NCT00177944
COMPLETED Phase 1

3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women

NCT00222872
COMPLETED

Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation

NCT00654771
COMPLETED Phase 1

The Effect of HealthWear on Short-Term Weight Loss

NCT00177593
COMPLETED

Living With Fibromyalgia: Triggers,Subgroups, and a Cognitive-Behavioral and Interactive Technology-Based Intervention

NCT00222690
COMPLETED Phase 4

PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra

NCT00269620
COMPLETED

Gram Negative Bacteremia, Risk Factors for Failure of Therapy

NCT00177957
COMPLETED

PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans

NCT00222768
TERMINATED Phase 2

A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

NCT00177255
TERMINATED Phase 2

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

NCT00177775
COMPLETED

Rheumatic Diseases and Computer Use

NCT00177320
COMPLETED

Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting

NCT00222859
COMPLETED

Longitudinal Assessment of Bariatric Surgery

NCT00433810
COMPLETED

Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

NCT00585364
COMPLETED

Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit

NCT00177931
COMPLETED Phase 3

Computer-assisted Preventive Health Education for Women of Reproductive Age in Urgent Care Settings

NCT00177515
COMPLETED Phase 1

Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight

NCT00226213
COMPLETED Phase 1

Menopause and Meditation for Breast Cancer Survivors

NCT00156416
COMPLETED Phase 3

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery

NCT00109954
COMPLETED Phase 4

Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings

NCT00177398
COMPLETED NA

A Trial of Two On-Line Interventions for Child Brain Injury

NCT00178022
COMPLETED

Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

NCT00167375
COMPLETED

The Genetic Basis of Atrial Fibrillation (AF)

NCT00248326
COMPLETED Phase 4

Mifepristone and Misoprostol for Fetal Demise

NCT00177372
COMPLETED Phase 2

Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer

NCT00177307
COMPLETED Phase 4

Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery

NCT00688636
TERMINATED

Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart Surgery

NCT00248274
COMPLETED Phase 4

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

NCT00105586
← Previous Page 22 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

Therapeutic Areas

Depression 17
Obesity 16
Sleep 10
Stroke 10
Cancer 10
Diabetes 7
Chronic Pain 7
Sleep Disturbance 6
Anxiety 6
Bipolar Disorder 5

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.